Relaxo Footwears Q1 Results Review - Volume Performance Remain Impacted: Dolat Capital

Dolat Capital Report

Relaxo Footwear Ltd.’s results were below our estimate. Revenues grew 1.3% YoY versus our estimate of 5%. However, growth is expected to accelerate with improvement in demand and favorable base. Gross margin expanded 460 basis points to 62.0% aided by lower raw material prices. However, Ebitdam contracted by 130 bps to 13.2% due to high employee costs and other expenses. Lower operating leverage due to lower revenues resulted in Ebitda contraction.

We downward revise our FY25/26E earnings per share estimates by 7.1/6.6% at Rs 10.8/13.2, owing to lower-than-expected Q1 FY25 results. However, we continue to believe that the company can deliver double-digit revenue growth on a favorable base.

Valuing the stock at 58 times FY26E we arrive at a target price of Rs 774. Given rich valuation, we maintain our ‘Sell’ rating.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.